Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
British Journal of Haematology
|
October 20, 2010
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers
Lillian McMahon, Hannah Tamary, Melissa Askin, et al.
Hepatology (Baltimore, Md.)
|
April 28, 2007
Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C
Robert J Fontana, Linas A Bieliauskas, Karen L Lindsay, et al.
Antiviral Research
|
May 25, 2019
Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years
Pallavi Surana, Devika Kapuria, Carly Broadwell, et al.
Gut
|
August 3, 2010
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
Robert J Fontana, Jules L Dienstag, Herbert L Bonkovsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 29, 2016
Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C
Niharika Samala, Elizabeth C Wright, A Gretchen Buckler, et al.
Alimentary Pharmacology & Therapeutics
|
March 18, 2024
Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation
Asif A Hitawala, Harish Gopalakrishna, Maria Mironova, et al.
Hepatology (Baltimore, Md.)
|
May 25, 2013
Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis
Mazen Noureddin, Elizabeth C Wright, Harvey J Alter, et al.
Hepatology (Baltimore, Md.)
|
October 28, 2011
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial
Gregory T Everson, Mitchell L Shiffman, John C Hoefs, et al.
Cells
|
September 27, 2024
A Novel Non-Invasive Murine Model of Neonatal Hypoxic-Ischemic Encephalopathy Demonstrates Developmental Delay and Motor Deficits with Activation of Inflammatory Pathways in Monocytes
Elise A Lemanski, Bailey A Collins, Andrew T Ebenezer, et al.
The American Journal of Gastroenterology
|
October 3, 2002
Use of complementary and alternative medicine in patients with liver disease
Doris B Strader, Bruce R Bacon, Karen L Lindsay, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
British Journal of Haematology
|
October 20, 2010
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers
Lillian McMahon, Hannah Tamary, Melissa Askin, et al.
Hepatology (Baltimore, Md.)
|
April 28, 2007
Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C
Robert J Fontana, Linas A Bieliauskas, Karen L Lindsay, et al.
Antiviral Research
|
May 25, 2019
Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years
Pallavi Surana, Devika Kapuria, Carly Broadwell, et al.
Gut
|
August 3, 2010
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
Robert J Fontana, Jules L Dienstag, Herbert L Bonkovsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 29, 2016
Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C
Niharika Samala, Elizabeth C Wright, A Gretchen Buckler, et al.
Alimentary Pharmacology & Therapeutics
|
March 18, 2024
Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation
Asif A Hitawala, Harish Gopalakrishna, Maria Mironova, et al.
Hepatology (Baltimore, Md.)
|
May 25, 2013
Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis
Mazen Noureddin, Elizabeth C Wright, Harvey J Alter, et al.
Hepatology (Baltimore, Md.)
|
October 28, 2011
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial
Gregory T Everson, Mitchell L Shiffman, John C Hoefs, et al.
Cells
|
September 27, 2024
A Novel Non-Invasive Murine Model of Neonatal Hypoxic-Ischemic Encephalopathy Demonstrates Developmental Delay and Motor Deficits with Activation of Inflammatory Pathways in Monocytes
Elise A Lemanski, Bailey A Collins, Andrew T Ebenezer, et al.
The American Journal of Gastroenterology
|
October 3, 2002
Use of complementary and alternative medicine in patients with liver disease
Doris B Strader, Bruce R Bacon, Karen L Lindsay, et al.
Page
of 8